Published May 2019 | Version v1
Journal article Metadata-only

First experience of durable cytoreduction in chronic lymphoid leukemia with 177Lu-DOTATATE

Creators

  • 1. CHUV, Nuclear Medicine Department and Molecular Imaging (Switzerland)
  • 2. Medical Oncology, Clinique Bois-Cerf (Switzerland)
  • 3. Interal Medicine, Centre Médical du Bouveret (Switzerland)

Description

This is the first described case of effective and durable cytoreduction after PRRT with 177Lu-DOTATATE in a 75-year-old female, with B cell chronic lymphoid leukemia, and well-differentiated metastatic neuroendocrine tumor.

Additional details

Identifiers

DOI
10.1007/s12032-019-1266-0;

Publishing Information

Journal Title
Medical Oncology (Online)
Journal Volume
36
Journal Issue
5
Journal Page Range
p. 1-3
ISSN
1559-131X

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51102483
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
FEMALES; LEUKEMIA; LUTETIUM 177; METASTASES; POSITRON COMPUTED TOMOGRAPHY
Descriptors DEC
BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; COMPUTERIZED TOMOGRAPHY; DAYS LIVING RADIOISOTOPES; DIAGNOSTIC TECHNIQUES; DISEASES; EMISSION COMPUTED TOMOGRAPHY; IMMUNE SYSTEM DISEASES; INTERMEDIATE MASS NUCLEI; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LUTETIUM ISOTOPES; NEOPLASMS; NUCLEI; ODD-EVEN NUCLEI; RADIOISOTOPES; RARE EARTH NUCLEI; TOMOGRAPHY

Optional Information

Copyright
Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature
Notes
http://www.springer-ny.com